CLOCK BIO
LIVE

Serial Number

79318748

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

Mar 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CLOCK BIO Trademark

Serial Number: 79318748 • Registration: 6841513

CLOCK BIO is a trademark filed by Bit Bio Limited on March 22, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Clock Bio Limited (2 trademarks)

C/o PEM,

Entity Type: 98

Trademark Details

Filing Date

March 22, 2021

Registration Date

September 13, 2022

Published for Opposition

June 28, 2022

Goods & Services

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements, nutrition supplements, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medical, clinical, research and biomanufacturing purposes, namely downloadable and recorded software for conducting medical and clinical research and to control laboratory manufacturing robots; bioreactors for laboratory use, namely, biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory automation equipment; laboratory apparatus for magnetic cell separation namely, apparatus for the separation of cell populations for medical or clinical use

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Pharmaceuticals in the natures of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells for medical, therapeutic or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical, therapeutic or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use for drug screening for medical, therapeutic or clinical use; cell preparations for genetic testing, screening for medical or clinical purposes; stem cells for medical purposes; stem cells for veterinary purposes; tissue culture media growth factors in the nature of cell growth, cell growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells for medical, therapeutic or clinical purposes; cell separation reagents for medical, therapeutic or clinical purposes

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use, not for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for research use; cell preparations for drug screening for research use; genetically or otherwise modified cells for research use; cells which are propagated, cultivated and expanded in bioreactors for research use

Biotechnology research; biotechnology testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely biological research; stem cell biology services, namely biological research; scientific services for scientific, research, clinical, medical, and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; scientific research and development in relation to genetic testing, screening; scientific research and development in relation to drug screening; cell separation technology services for scientific, research, clinical, medical, and manufacturing purposes; cell separation research services; consultancy relating to biotechnology; scientific and research consultancy relating to drug screening; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discovery; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; development and testing of computing methods, software algorithms and software for medical, clinical, research and biomanufacturing purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
CHANGE OF OWNER RECEIVED FROM IB
Oct 25, 2024 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 9, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 15, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 15, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2022 TROA
REFUSAL PROCESSED BY IB
Dec 26, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 6, 2021 RFCS
REFUSAL PROCESSED BY MPU
Dec 6, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 4, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 3, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 4, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 26, 2021 REPR